Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01198834 · ClinicalTrials.gov registry record · Phase 3

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

A Phase 3 study of Ankle Sprains, sponsored by MEDRx USA.

Completed
Registry status
Phase 3
Development phase
600
Enrollment target
20
Study locations

NCT01198834 is a Phase 3 study of Ankle Sprains that has completed, run by MEDRx USA. The registered enrollment target is 600 participants, above the 109-participant average among 4 other Ankle Sprains trials with a reported enrollment target (450% higher). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01198834, a Phase 3 study of Ankle Sprains, has completed, sponsored by MEDRx USA.

COMPLETED
Registry status
Phase 3
Development phase
600 participants
Enrollment target
20
Study locations

Study Summary

A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Lidocaine
  • DRUG Etodolac
  • DRUG MRX-7EAT

Study Locations (20)

Florida

  • - Daytona Beach
  • - Fort Lauderdale
  • - Gulf Breeze
  • - Orlando
  • - West Palm Beach

Indiana

  • - Avon
  • - Fishers
  • - Franklin
  • - Greenfield
  • - Muncie

California

  • - Chico
  • - Palm Springs
  • - San Diego

Colorado

  • - Aurora
  • - Colorado Springs
  • - Denver

Arizona

  • - Phoenix

Arkansas

  • - North Little Rock

Idaho

  • - Boise

Iowa

  • - Dubuque

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2010-09
Est. Completion 2011-06
Phase Phase 3

Sponsor

MEDRx USA

5 total trials

What the Registry Record Tells You About NCT01198834

The ClinicalTrials.gov registry entry for NCT01198834 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 109-participant average among 4 other Ankle Sprains trials with a reported enrollment target (450% higher). The listed sponsor is MEDRx USA, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ankle Sprains appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT01198834 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Florida, Indiana, California.

Frequently Asked Questions

What is clinical trial NCT01198834 about?

NCT01198834 is a clinical study titled "MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains". A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

What is the current status of trial NCT01198834?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2010-09. Estimated completion is 2011-06.

What conditions does trial NCT01198834 study?

This clinical trial studies the following conditions: Ankle Sprains.

What interventions are being tested in trial NCT01198834?

The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG), Etodolac (DRUG), MRX-7EAT (DRUG).

Who is sponsoring clinical trial NCT01198834?

This trial is sponsored by MEDRx USA, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01198834 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ankle Sprains

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.